Bottom line
Is DCDGX a good fund? The bottom line
DCDGX is a share class of Dunham Small Cap Growth Fund, a managed small-cap mutual fund from Dunham.
It charges 2.25% — about $225 a year on every $10,000 invested, more expensive than 98% of small-cap funds we track.
With $79.9 million in net assets and 111 holdings, its largest position is Fidelity Colchester Street Trust (3.1%) and the top 10 make up 17.1% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (2.25%)
- 12b-1 marketing fee of 1% a year
- High turnover (153% a year) can mean more taxable distributions
Updated Nov 19, 2026
What DCDGX invests in
The Fund seeks to maximize capital appreciation.
The Fund?s Sub-Adviser seeks to achieve the Fund?s investment objective by investing primarily in domestic growth-oriented, small-capitalization or ?small-cap? common stocks of companies traded on U.S. stock exchanges or in the over-the-counter market using its proprietary stock selection process. Under normal market conditions, the Fund invests at least 80% of its assets (defined as net assets plus borrowing for investment purposes) in small cap companies. The Fund defines small capitalization companies as those companies whose market capitalizations are equal to or less than the largest company in the Russell 2000 Index during the most recent 12-month period. For the most recent annual reconstitution published as of June 2025, the maximum market capitalization of companies in the Russell 2000 Index was approximately $15.7 billion, which will vary daily. The Sub-Adviser attempts to…
From the fund's prospectus (filed Feb 27, 2026).
What DCDGX costs
On a $10,000 investment, DCDGX's 2.25% expense ratio costs about $225 a year. The prospectus estimates $2,585 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
DCDGX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Fidelity Colchester Street Trust | 3.13% |
| 2 | Esco Technologies Inc | 1.82% |
| 3 | Hexcel Corp | 1.79% |
| 4 | Fulton Financial Corp | 1.57% |
| 5 | Establishment Labs Holdings Inc | 1.56% |
| 6 | Valmont Industries Inc | 1.55% |
| 7 | Angiodynamics Inc | 1.47% |
| 8 | Imax Corp | 1.42% |
| 9 | Kodiak Gas Services Inc | 1.39% |
| 10 | Repligen Corp | 1.38% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 17.1% of the fund. See all top 25 holdings and asset mix →